Kennedy Capital Management LLC Boosts Stock Position in Addus HomeCare Corporation $ADUS

Kennedy Capital Management LLC increased its stake in Addus HomeCare Corporation (NASDAQ:ADUS) by 34.3% in the 2nd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 178,801 shares of the company’s stock after purchasing an additional 45,670 shares during the quarter. Kennedy Capital Management LLC owned about 0.97% of Addus HomeCare worth $20,596,000 at the end of the most recent quarter.

A number of other institutional investors have also added to or reduced their stakes in ADUS. Avantax Advisory Services Inc. grew its holdings in Addus HomeCare by 38.9% during the 1st quarter. Avantax Advisory Services Inc. now owns 3,255 shares of the company’s stock valued at $322,000 after buying an additional 911 shares in the last quarter. Cynosure Group LLC grew its stake in Addus HomeCare by 491.3% during the first quarter. Cynosure Group LLC now owns 14,415 shares of the company’s stock valued at $1,425,000 after acquiring an additional 11,977 shares in the last quarter. Connor Clark & Lunn Investment Management Ltd. grew its stake in Addus HomeCare by 57.7% during the first quarter. Connor Clark & Lunn Investment Management Ltd. now owns 21,598 shares of the company’s stock valued at $2,136,000 after acquiring an additional 7,903 shares in the last quarter. Invesco Ltd. increased its holdings in Addus HomeCare by 19.8% during the 1st quarter. Invesco Ltd. now owns 414,705 shares of the company’s stock worth $41,010,000 after acquiring an additional 68,585 shares during the period. Finally, King Luther Capital Management Corp lifted its stake in Addus HomeCare by 35.3% in the 1st quarter. King Luther Capital Management Corp now owns 45,591 shares of the company’s stock worth $4,508,000 after purchasing an additional 11,900 shares in the last quarter. Hedge funds and other institutional investors own 95.35% of the company’s stock.

Addus HomeCare Trading Down 1.8%

Shares of ADUS opened at $117.89 on Thursday. Addus HomeCare Corporation has a fifty-two week low of $88.96 and a fifty-two week high of $136.72. The firm has a market cap of $2.18 billion, a price-to-earnings ratio of 25.24, a PEG ratio of 1.62 and a beta of 0.94. The firm has a 50 day moving average price of $116.17 and a 200-day moving average price of $113.74. The company has a debt-to-equity ratio of 0.14, a quick ratio of 1.66 and a current ratio of 1.66.

Addus HomeCare (NASDAQ:ADUS) last issued its earnings results on Monday, November 3rd. The company reported $1.56 EPS for the quarter, topping analysts’ consensus estimates of $1.53 by $0.03. Addus HomeCare had a net margin of 6.36% and a return on equity of 9.53%. The company had revenue of $362.30 million for the quarter, compared to analysts’ expectations of $354.48 million. During the same quarter last year, the company earned $1.30 EPS. The firm’s revenue was up 25.0% compared to the same quarter last year. As a group, equities research analysts forecast that Addus HomeCare Corporation will post 4.59 earnings per share for the current year.

Insiders Place Their Bets

In related news, EVP Darby Anderson sold 20,000 shares of the stock in a transaction dated Wednesday, November 19th. The stock was sold at an average price of $109.00, for a total transaction of $2,180,000.00. Following the completion of the sale, the executive vice president directly owned 44,144 shares in the company, valued at $4,811,696. This represents a 31.18% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. 4.50% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

A number of research analysts have recently commented on ADUS shares. Weiss Ratings restated a “hold (c+)” rating on shares of Addus HomeCare in a research report on Wednesday, October 8th. Barclays lifted their price objective on Addus HomeCare from $111.00 to $117.00 and gave the company an “underweight” rating in a research note on Tuesday, November 4th. Cowen restated a “buy” rating on shares of Addus HomeCare in a research note on Wednesday, November 5th. Royal Bank Of Canada lifted their price target on Addus HomeCare from $134.00 to $139.00 and gave the company an “outperform” rating in a research report on Friday, November 7th. Finally, Stephens reissued an “overweight” rating and set a $140.00 price objective on shares of Addus HomeCare in a report on Wednesday, September 3rd. One investment analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $137.11.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.